Your browser doesn't support javascript.
A compilation answering 50 questions on monkeypox virus and the current monkeypox outbreak.
Cabanillas, Beatriz; Murdaca, Giuseppe; Guemari, Amir; Torres, Maria Jose; Azkur, Ahmet Kursat; Aksoy, Emel; Vitte, Joana; de Las Vecillas, Leticia; Giovannini, Mattia; Fernández-Santamaria, Ruben; Castagnoli, Riccardo; Orsi, Andrea; Amato, Rosa; Giberti, Irene; Català, Alba; Ambrozej, Dominika; Schaub, Bianca; Tramper-Stranders, Gerdien A; Novak, Natalija; Nadeau, Kari C; Agache, Ioana; Akdis, Mubeccel; Akdis, Cezmi A.
  • Cabanillas B; Department of Allergy, Instituto de Investigacion Sanitaria Hospital 12 de Octubre (imas12), Madrid, Spain.
  • Murdaca G; Departments of Internal Medicine, University of Genova, Genova, Italy.
  • Guemari A; Aix-Marseille Univ, IRD, MEPHI, IHU Méditerranée Infection, Marseille, France.
  • Torres MJ; Allergy Unit, Hospital Regional Universitario de Málaga-ARADyAL, Málaga, Spain.
  • Azkur AK; Department of Virology, Faculty of Veterinary Medicine, Kirikkale University, Kirikkale, Turkey.
  • Aksoy E; Department of Virology, Faculty of Veterinary Medicine, Kirikkale University, Kirikkale, Turkey.
  • Vitte J; Aix-Marseille Univ, IRD, MEPHI, IHU Méditerranée Infection, Marseille, France.
  • de Las Vecillas L; Montpellier University, IDESP INSERM UMR UA 11, Montpellier, France.
  • Giovannini M; Department of Allergy, La Paz University Hospital, IdiPAZ, Madrid, Spain.
  • Fernández-Santamaria R; Allergy Unit, Department of Pediatrics, Meyer Children's Hospital, Florence, Italy.
  • Castagnoli R; Department of Health Sciences, University of Florence, Florence, Italy.
  • Orsi A; Allergy Research Group, Instituto de Investigación Biomédica de Málaga-IBIMA, Málaga, Spain.
  • Amato R; Department of Clinical, Surgical, Diagnostic and Pediatric Sciences, University of Pavia, Pavia, Italy.
  • Giberti I; Pediatric Clinic, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.
  • Català A; Department of Health Sciences, University of Genova, Genova, Italy.
  • Ambrozej D; Department of Health Sciences, University of Genova, Genova, Italy.
  • Schaub B; Department of Health Sciences, University of Genova, Genova, Italy.
  • Tramper-Stranders GA; Dermatology Department, Sexually Transmitted Diseases Clinic, Hospital Clinic, Barcelona, Spain.
  • Novak N; Department of Pediatric Pneumonology and Allergy, Medical University of Warsaw, Warsaw, Poland.
  • Nadeau KC; Doctoral School, Medical University of Warsaw, Warsaw, Poland.
  • Agache I; Pediatric Allergology, Department of Pediatrics, Dr. von Hauner Children's Hospital, University Hospital, LMU, Munich, Germany.
  • Akdis M; Member of German Center for Lung Research - DZL, LMU, Munich, Germany.
  • Akdis CA; Franciscus Gasthuis & Vlietland, Rotterdam, The Netherlands.
Allergy ; 78(3): 639-662, 2023 03.
Artículo en Inglés | MEDLINE | ID: covidwho-20233683
ABSTRACT
The current monkeypox disease (MPX) outbreak constitutes a new threat and challenge for our society. With more than 55,000 confirmed cases in 103 countries, World Health Organization declared the ongoing MPX outbreak a Public Health Emergency of International Concern (PHEIC) on July 23, 2022. The current MPX outbreak is the largest, most widespread, and most serious since the diagnosis of the first case of MPX in 1970 in the Democratic Republic of the Congo (DRC), a country where MPX is an endemic disease. Throughout history, there have only been sporadic and self-limiting outbreaks of MPX outside Africa, with a total of 58 cases described from 2003 to 2021. This figure contrasts with the current outbreak of 2022, in which more than 55,000 cases have been confirmed in just 4 months. MPX is, in most cases, self-limiting; however, severe clinical manifestations and complications have been reported. Complications are usually related to the extent of virus exposure and patient health status, generally affecting children, pregnant women, and immunocompromised patients. The expansive nature of the current outbreak leaves many questions that the scientific community should investigate and answer in order to understand this phenomenon better and prevent new threats in the future. In this review, 50 questions regarding monkeypox virus (MPXV) and the current MPX outbreak were answered in order to provide the most updated scientific information and to explore the potential causes and consequences of this new health threat.
Asunto(s)
Palabras clave

Texto completo: Disponible Colección: Bases de datos internacionales Base de datos: MEDLINE Asunto principal: Monkeypox virus / Mpox Tipo de estudio: Estudios diagnósticos / Estudio observacional / Estudio pronóstico Límite: Niño / Femenino / Humanos / Embarazo Idioma: Inglés Revista: Allergy Año: 2023 Tipo del documento: Artículo País de afiliación: All.15633

Similares

MEDLINE

...
LILACS

LIS


Texto completo: Disponible Colección: Bases de datos internacionales Base de datos: MEDLINE Asunto principal: Monkeypox virus / Mpox Tipo de estudio: Estudios diagnósticos / Estudio observacional / Estudio pronóstico Límite: Niño / Femenino / Humanos / Embarazo Idioma: Inglés Revista: Allergy Año: 2023 Tipo del documento: Artículo País de afiliación: All.15633